Dr Carolyn Taylor
BM BCh (oxon) MA MRCP FRCR DPhil
Associate Professor, Clinical Research Fellow and Honorary Consultant Oncologist
Carolyn Taylor is a consultant clinical oncologist and clinical research fellow. She studied medicine at Oxford University. Her clinical training was in general medicine and then clinical oncology. She gained Fellowship of the Royal College of Radiologists in 2004.
Since then she has worked as a clinical research fellow at the Clinical Trial Service Unit, doing research alongside clinical work. She completed her DPhil on the risk of heart disease after breast cancer radiotherapy in 2008. She works in the Early Breast Cancer Trialists’ Collaborative Group on trials of surgery and radiotherapy and in a Cancer Research UK research program on the benefits and risks of breast cancer treatments.
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.
Kerr AJ. et al, (2022), Cancer Treat Rev, 105
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: patient level meta-analysis of 7,030 women in four randomised trials
BRADLEY R. et al, (2021), The Lancet Oncology
Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.
Duane FK. et al, (2021), Radiother Oncol
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150
Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophageal doses published 2013–2018
Duane F. et al, (2020), European Journal of Cancer, 138, S83 - S84